Rasburicase (Vietnamese Wikipedia)

Analysis of information sources in references of the Wikipedia article "Rasburicase" in Vietnamese language version.

refsWebsite

Global rank Vietnamese rank

7nih.gov

4^th place

7^th place

5doi.org

2^nd place

2rxlist.com

7,927^th place

low place

1elitekpro.com

low place

1europa.eu

68^th place

114^th place

1asnjournals.org

low place

1archive.today

14^th place

27^th place

1metapress.com

8,671^st place

7,939^th place

1bmj.com

1,226^th place

1,573^rd place

archive.today

Ho VQ, Wetzstein GA, Patterson SG, Bradbury R (tháng 4 năm 2006). “Abbreviated rasburicase dosing for the prevention and treatment of hyperuricemia in adults at risk for tumor lysis syndrome”. Supportive Cancer Therapy. 3 (3): 178–82. doi:10.3816/SCT.2006.n.016. PMID 18632493. Bản gốc lưu trữ ngày 28 tháng 1 năm 2013.

asnjournals.org

cjasn.asnjournals.org

Wilson FP, Berns JS (tháng 10 năm 2012). “Onco-nephrology: tumor lysis syndrome”. Clin J Am Soc Nephrol. 7 (10): 1730–9. doi:10.2215/CJN.03150312. PMID 22879434.

bmj.com

ard.bmj.com

Reinders MK, van Roon EN, Brouwers JR, Jansen TL (tháng 3 năm 2005). “A costly therapeutic dilemma in tophaceous gout: is etanercept or rasburicase preferable?”. Annals of the Rheumatic Diseases. 64 (3): 516, author reply 516. doi:10.1136/ard.2003.017087corr1. PMC 1755382. PMID 15708917.

doi.org

Wilson FP, Berns JS (tháng 10 năm 2012). “Onco-nephrology: tumor lysis syndrome”. Clin J Am Soc Nephrol. 7 (10): 1730–9. doi:10.2215/CJN.03150312. PMID 22879434.
Ho VQ, Wetzstein GA, Patterson SG, Bradbury R (tháng 4 năm 2006). “Abbreviated rasburicase dosing for the prevention and treatment of hyperuricemia in adults at risk for tumor lysis syndrome”. Supportive Cancer Therapy. 3 (3): 178–82. doi:10.3816/SCT.2006.n.016. PMID 18632493. Bản gốc lưu trữ ngày 28 tháng 1 năm 2013.
Cheuk, DK; Chiang, AK; Chan, GC; Ha, SY (14 tháng 8 năm 2014). “Urate oxidase for the prevention and treatment of tumour lysis syndrome in children with cancer”. The Cochrane Database of Systematic Reviews. 8 (8): CD006945. doi:10.1002/14651858.CD006945.pub3. PMID 25121561.
Reinders MK, van Roon EN, Brouwers JR, Jansen TL (tháng 3 năm 2005). “A costly therapeutic dilemma in tophaceous gout: is etanercept or rasburicase preferable?”. Annals of the Rheumatic Diseases. 64 (3): 516, author reply 516. doi:10.1136/ard.2003.017087corr1. PMC 1755382. PMID 15708917.
Cammalleri L, Malaguarnera M (2007). “Rasburicase represents a new tool for hyperuricemia in tumor lysis syndrome and in gout”. International Journal of Medical Sciences. 4 (2): 83–93. doi:10.7150/ijms.4.83. PMC 1838823. PMID 17396159.

elitekpro.com

“ELITEK is the Only Agent Proven to Maintain Normal Uric Acid Levels in Significantly More Patients vs allopurinol”.

europa.eu

ema.europa.eu

“Fasturtec”.

metapress.com

cigjournals.metapress.com

Ho VQ, Wetzstein GA, Patterson SG, Bradbury R (tháng 4 năm 2006). “Abbreviated rasburicase dosing for the prevention and treatment of hyperuricemia in adults at risk for tumor lysis syndrome”. Supportive Cancer Therapy. 3 (3): 178–82. doi:10.3816/SCT.2006.n.016. PMID 18632493. Bản gốc lưu trữ ngày 28 tháng 1 năm 2013.

nih.gov

pubmed.ncbi.nlm.nih.gov

Wilson FP, Berns JS (tháng 10 năm 2012). “Onco-nephrology: tumor lysis syndrome”. Clin J Am Soc Nephrol. 7 (10): 1730–9. doi:10.2215/CJN.03150312. PMID 22879434.
Ho VQ, Wetzstein GA, Patterson SG, Bradbury R (tháng 4 năm 2006). “Abbreviated rasburicase dosing for the prevention and treatment of hyperuricemia in adults at risk for tumor lysis syndrome”. Supportive Cancer Therapy. 3 (3): 178–82. doi:10.3816/SCT.2006.n.016. PMID 18632493. Bản gốc lưu trữ ngày 28 tháng 1 năm 2013.
Cheuk, DK; Chiang, AK; Chan, GC; Ha, SY (14 tháng 8 năm 2014). “Urate oxidase for the prevention and treatment of tumour lysis syndrome in children with cancer”. The Cochrane Database of Systematic Reviews. 8 (8): CD006945. doi:10.1002/14651858.CD006945.pub3. PMID 25121561.
Reinders MK, van Roon EN, Brouwers JR, Jansen TL (tháng 3 năm 2005). “A costly therapeutic dilemma in tophaceous gout: is etanercept or rasburicase preferable?”. Annals of the Rheumatic Diseases. 64 (3): 516, author reply 516. doi:10.1136/ard.2003.017087corr1. PMC 1755382. PMID 15708917.
Cammalleri L, Malaguarnera M (2007). “Rasburicase represents a new tool for hyperuricemia in tumor lysis syndrome and in gout”. International Journal of Medical Sciences. 4 (2): 83–93. doi:10.7150/ijms.4.83. PMC 1838823. PMID 17396159.

ncbi.nlm.nih.gov

Reinders MK, van Roon EN, Brouwers JR, Jansen TL (tháng 3 năm 2005). “A costly therapeutic dilemma in tophaceous gout: is etanercept or rasburicase preferable?”. Annals of the Rheumatic Diseases. 64 (3): 516, author reply 516. doi:10.1136/ard.2003.017087corr1. PMC 1755382. PMID 15708917.
Cammalleri L, Malaguarnera M (2007). “Rasburicase represents a new tool for hyperuricemia in tumor lysis syndrome and in gout”. International Journal of Medical Sciences. 4 (2): 83–93. doi:10.7150/ijms.4.83. PMC 1838823. PMID 17396159.

rxlist.com

“ELITEK”.
“Elitek (rasburicase)”. Rxlist.